Discovery of anti-MERS-CoV small covalent inhibitors through pharmacophore modeling, covalent docking and molecular dynamics simulation

Middle east respiratory syndrome coronavirus (MERS-CoV) is a fatal pathogen that poses a serious health risk worldwide and especially in the middle east countries. Targeting the MERS-CoV 3-chymotrypsin-like cysteine protease (3CL(pro)) with small covalent inhibitors is a significant approach to inhi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Mol Liq
Hlavní autoři: Alamri, Mubarak A., Tahir ul Qamar, Muhammad, Afzal, Obaid, Alabbas, Alhumaidi B., Riadi, Yassine, Alqahtani, Safar M.
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier B.V. 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8040153/
https://ncbi.nlm.nih.gov/pubmed/33867606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molliq.2021.115699
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky